Stay updated on Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedLocations now include Shanghai Municipality and a new publication citation for Fruquintinib plus sintilimab (Nat Commun 2025). The record revision is updated to v3.3.3, replacing the prior v3.3.2 entry.SummaryDifference0.3%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedAdded a note that PubMed publications are automatically populated from PubMed and may not all relate to the study. The page revision was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check48 days agoChange DetectedThe site-wide funding/operating status notice was removed. This does not affect the study details or data shown on the page.SummaryDifference0.4%

- Check63 days agoChange DetectedNo additions or deletions detected on the page; the Study Details content appears unchanged.SummaryDifference0.5%

- Check91 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference2%

- Check98 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.0%

Stay in the know with updates to Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib and Sintilimab in Advanced Solid Tumors Clinical Trial page.